The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
EDSA · Healthcare · No moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
RNLXY · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | EDSA | RNLXY | HYPR | LUCD |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | — | 30 | 65 | 70 (highest) |
| Pricing power | 32 (highest) | 22 | 21 | 22 |
| Returns on capital | 0 (highest) | — | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 55 (highest) | 28 |
| Capital allocation | 44 (highest) | 24 | 24 | 44 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | $37.5M | Not reported | $78M | $119M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2024 | FY2025 | FY2025 |